# Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)

> **NCT07389018** · — · NOT_YET_RECRUITING · sponsor: **SYSNAV** · enrollment: 30 (estimated)

## Conditions studied

- Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07389018
- **Lead sponsor:** SYSNAV
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07389018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07389018, "Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07389018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*